We would emphasise that all included studies were surveying what at the time was thought to be AQP4 antibody-associated NMOSD although it is now recognised that the earlier criteria are likely to have included a heterogeneous group of diagnoses including MOGAD and MS. The gene discussed is AQP4; the disease is myeloid sarcoma.